SG Americas Securities LLC Lowers Holdings in STERIS plc $STE

SG Americas Securities LLC trimmed its stake in STERIS plc (NYSE:STE) by 44.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,361 shares of the medical equipment provider’s stock after selling 10,764 shares during the quarter. SG Americas Securities LLC’s holdings in STERIS were worth $3,210,000 at the end of the most recent quarter.

Other institutional investors have also recently modified their holdings of the company. Foresight Group Ltd Liability Partnership purchased a new stake in shares of STERIS during the first quarter valued at approximately $25,958,000. KLP Kapitalforvaltning AS raised its holdings in STERIS by 5.3% in the 2nd quarter. KLP Kapitalforvaltning AS now owns 33,800 shares of the medical equipment provider’s stock worth $8,119,000 after acquiring an additional 1,700 shares during the last quarter. Ascent Group LLC bought a new position in STERIS in the 1st quarter valued at approximately $261,000. Allianz Asset Management GmbH boosted its stake in STERIS by 31.9% during the 1st quarter. Allianz Asset Management GmbH now owns 102,488 shares of the medical equipment provider’s stock valued at $23,229,000 after purchasing an additional 24,809 shares during the last quarter. Finally, Truist Financial Corp increased its holdings in shares of STERIS by 116.2% in the 2nd quarter. Truist Financial Corp now owns 31,064 shares of the medical equipment provider’s stock worth $7,462,000 after purchasing an additional 16,694 shares in the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at STERIS

In other STERIS news, CEO Daniel A. Carestio sold 159 shares of the business’s stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $241.82, for a total transaction of $38,449.38. Following the completion of the sale, the chief executive officer owned 51,096 shares of the company’s stock, valued at approximately $12,356,034.72. The trade was a 0.31% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP John Adam Zangerle sold 15,000 shares of the company’s stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total value of $3,977,100.00. Following the completion of the sale, the vice president owned 33,669 shares of the company’s stock, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their position. The SEC filing for this sale provides additional information. Company insiders own 1.07% of the company’s stock.

STERIS Stock Up 0.1%

STE stock opened at $257.15 on Wednesday. The company has a market cap of $25.24 billion, a price-to-earnings ratio of 39.38 and a beta of 1.02. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.53 and a current ratio of 2.22. The business’s 50-day moving average is $246.32 and its two-hundred day moving average is $240.93. STERIS plc has a fifty-two week low of $200.98 and a fifty-two week high of $268.30.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 EPS for the quarter, beating the consensus estimate of $2.38 by $0.09. STERIS had a net margin of 11.61% and a return on equity of 14.17%. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter in the prior year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. As a group, analysts forecast that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be given a $0.63 dividend. The ex-dividend date is Tuesday, November 18th. This represents a $2.52 annualized dividend and a yield of 1.0%. STERIS’s dividend payout ratio (DPR) is presently 36.21%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a report on Sunday, September 14th. KeyCorp upped their target price on shares of STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a research note on Tuesday, July 22nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Tuesday, October 14th. Finally, Morgan Stanley boosted their price objective on shares of STERIS from $276.00 to $295.00 and gave the company an “overweight” rating in a report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $273.50.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.